CB1 Mediation of Cerebellum Versus Forebrain-Dependent Associative Learning

描述（由申请人提供）：大麻，或大麻，是美国最常用的非法药物。青少年和青年期吸毒水平增加，从公共卫生角度来看，这是一个令人关切的问题，因为这也是神经发育的关键时期。特别令人不安的是，每天新增6000多名首次使用大麻的人，其中62.2%的人年龄在18岁以下。由于大麻的使用可能使个人易于滥用其他非法药物，因此大麻可能成为一种入门药物，这一事实进一步突出了这种担心。此外，大麻的效力（Δ-9-四氢大麻酚（Δ 9-THC）的浓度）现在在美国超过10%（1983年为4%），这可能对正常的大脑功能产生不可预见的后果。鉴于大量的人谁消费大麻定期，一个彻底的了解与其行为和生理影响的神经机制是相当相关的。小脑可以说含有大脑中密度最高的CB 1受体。虽然众所周知，9-THC会导致认知功能异常，如短期记忆和注意力，但研究外源性大麻素对联想学习的影响的数据很少，特别是因为它与小脑与前脑依赖的经典眨眼条件反射（EBC）有关。我们小组的早期工作表明，在人类中，长期使用大麻改变了小脑依赖性延迟EBC中的条件反应（CR）获取和时间，但在前脑依赖性痕量EBC任务中则不然。然而，目前尚不清楚在慢性大麻使用者中观察到的缺陷是否是由于9- THC的残留作用，大麻中存在的一些其他大麻素，CB 1下调或寻求药物的个体的发病前差异。因此，本申请的总体目的是研究急性静脉内施用9- THC是否介导人的小脑依赖性与前脑依赖性联想学习，如分别用延迟和痕量EBC评估的。基于小脑中已知的CB 1作用，假设结果是9-THC（与安慰剂相比）将以剂量依赖性方式诱导小脑依赖性延迟EBC的损伤（CR百分比降低和CR潜伏期改变）。预计9-THC对前脑依赖性微量EBC的影响很小或没有影响。总之，希望这些研究的数据将进一步加深我们对大麻素系统的理解，特别是在联想学习的背景下，这将有助于阐明最常用的滥用药物之一的作用机制。

DESCRIPTION (provided by applicant): Marijuana, or Cannabis sativa, is the most commonly used illicit drug in the United States. Increased levels of use occur during adolescence and young adulthood, which is of concern from a public health perspective, since these are also critical periods of neural development. What is particularly disturbing is the fact that there are over 6000 first-time cannabis users added per day, 62.2 percent of which are under the age of eighteen. This fear is further underscored by the fact that cannabis may act as a gateway drug, since its use may predispose individuals to abuse other illicit drugs. Further, the potency of cannabis (concentration of delta-9- tetrahydrocannabinol (¿9-THC)), is now exceeding 10 percent in the U.S. (compared to 4 percent in 1983), which could have unforeseen consequences for normal brain function. Given the vast number of individuals who consume cannabis on a regular basis, a thorough understanding of the neural mechanisms associated with its behavioral and physiological effects are of considerable relevance. The cerebellum arguably contains the highest density of CB1 receptors in the brain. While it is well known that ¿9-THC causes abnormalities in cognitive functions such as short-term memory and attention, there are a paucity of data examining the effect of exogenous cannabinoids on associative learning, particularly as it relates to cerebellar versus forebrain-dependent classical eyeblink conditioning (EBC). Earlier work from our group has shown that in humans, chronic cannabis use alters conditioned response (CR) acquisition and timing in cerebellar-dependent delay EBC, but not in the forebrain-dependent trace EBC task. However, it remains unclear whether the deficits observed in chronic cannabis users are due to the residual effects of ¿9- THC, some other cannabinoid present in cannabis, CB1 downregulation, or premorbid differences in drug- seeking individuals. Therefore, the overall aim of the current application is to investigate whether acute, i.v. ¿9- THC administration mediates cerebellum- versus forebrain-dependent associative learning in humans as assessed with delay and trace EBC, respectively. The hypothesized outcome, based on known CB1 actions in the cerebellum, is that ¿9-THC (as compared to placebo) will induce impairments in cerebellar dependent delay EBC in a dose-dependent manner (decreased percent CRs and altered CR latency). It is also expected that ¿9-THC will have little or no effect on forebrain-dependent trace EBC. Taken together, it is hoped that data from these studies will further our understanding of the cannabinoid system, particularly in the context of associative learning, which will help elucidate the mechanism of action of one of the most commonly used drugs of abuse.